Log in or Sign up for Free to view tailored content for your specialty!
Anaphylaxis News
Q&A: Company seeks to expand neffy FDA approval to more pediatric patients
ARS Pharmaceuticals announced its submission of a supplemental new drug application to the FDA for neffy 1 mg for the treatment of type 1 allergic reactions in children who weigh between 33 lb and 66 lb.
GA2FA 2024 inspires attendees to think ‘inside the box’ to advance food allergy treatment
The Global Allergy and Asthma Excellence Network, or GA2LEN, will host its biannual global meeting from Sept. 5 to 7.
Top news of August: FDA neffy approval, women’s asthma health, APA-AAI conference, more
Healio has compiled August’s most-read news in asthma and allergy.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Updated anaphylaxis parameters expand definition of who is at risk
SAN ANTONIO — Recently updated practice parameters will help clinicians better recognize and treat anaphylaxis, Jeffrey Demain, MD, FAAAAI, FACAAI, FAAP, told Healio at the 16th Annual Allergy, Asthma & Immunology CME Conference.
EURneffy adrenaline nasal spray approved for use in the EU
The European Commission has approved EURneffy for the emergency treatment of allergic reactions, according to a press release by ARS Pharmaceuticals, producer of the drug.
Advocates ‘very excited’ by FDA approval of epinephrine nasal spray
Advocates were pleased to learn about the FDA’s approval of ARS Pharmaceuticals’ neffy epinephrine nasal spray, which may have a significant impact on the safety and quality of life of families with allergy.
FDA approves epinephrine nasal spray for anaphylaxis
The FDA has approved neffy epinephrine nasal spray for emergency treatment of Type 1 allergic reactions, including anaphylaxis, in pediatric and adult individuals weighing at least 66 pounds.
Lupin-induced anaphylaxis prevalence may be underestimated
A recent study published in the European Journal of Allergy and Clinical Immunology shows that significant cross-reactivity may exist between lupin and other legumes.
Top news of July: Anaphylaxis guidelines, epinephrine, FDA applications, more
Healio has compiled July’s most-read news in asthma and allergy.
Caregivers respond well after administering epinephrine during child oral food challenge
Giving young children an epinephrine autoinjection can be a positive and confidence-boosting experience for families, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read